Eyenovia Inc. (EYEN) NASDAQ
$1.75 0.09 (5.42%)
Market Cap: $55.72M
As of 08/10/22 04:00 PM EDT. Market closed.

Eyenovia Inc. (EYEN) NASDAQ
$1.75 0.09 (5.42%)
Market Cap: $55.72M
As of 08/10/22 04:00 PM EDT. Market closed.
Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and ... read more
Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Grant Stuart M. | 10% Owner | Jun 21, 2022 | Buy | $1.65 | 100,000 | 165,000 | 5,084,998 | Jun 23, 2022, 11:10 AM |
LEE KENNETH B JR | Director | May 19, 2022 | Buy | $2.20 | 10,000 | 22,000 | 42,322 | May 23, 2022, 08:49 AM |
MATHER CHARLES E IV | Director | May 18, 2022 | Buy | $2.03 | 7,000 | 14,232 | 48,322 | May 19, 2022, 08:27 AM |
Grant Stuart M. | 10% Owner | May 11, 2022 | Buy | $1.95 | 25,000 | 48,750 | 4,984,998 | May 12, 2022, 09:22 AM |
Grant Stuart M. | 10% Owner | May 10, 2022 | Buy | $1.98 | 50,000 | 99,000 | 4,959,998 | May 12, 2022, 09:22 AM |
Grant Stuart M. | 10% Owner | May 05, 2022 | Buy | $2.26 | 25,926 | 58,593 | 4,935,924 | May 05, 2022, 05:05 PM |
Grant Stuart M. | 10% Owner | May 04, 2022 | Buy | $2.26 | 24,074 | 54,407 | 4,909,998 | May 05, 2022, 05:05 PM |
Grant Stuart M. | 10% Owner | Apr 21, 2022 | Buy | $2.59 | 38,800 | 100,492 | 4,865,924 | Apr 25, 2022, 06:10 AM |
Grant Stuart M. | 10% Owner | Apr 22, 2022 | Buy | $2.55 | 20,000 | 51,000 | 4,885,924 | Apr 25, 2022, 06:10 AM |
MATHER CHARLES E IV | Director | Mar 31, 2022 | Buy | $3.12 | 4,000 | 12,460 | 41,322 | Mar 31, 2022, 09:24 PM |
Grant Stuart M. | 10% Owner | Feb 22, 2022 | Buy | $2.75 | 42,000 | 115,500 | 4,827,124 | Feb 23, 2022, 10:15 AM |
Grant Stuart M. | 10% Owner | Feb 18, 2022 | Buy | $2.85 | 10,000 | 28,500 | 4,785,124 | Feb 23, 2022, 10:15 AM |
Grant Stuart M. | 10% Owner | Feb 07, 2022 | Buy | $2.97 | 36,030 | 107,009 | 4,775,124 | Feb 08, 2022, 01:04 PM |
Grant Stuart M. | 10% Owner | Dec 15, 2021 | Buy | $3.45 | 100,000 | 345,000 | 4,723,989 | Dec 17, 2021, 09:30 AM |
Grant Stuart M. | 10% Owner | Nov 16, 2021 | Buy | $3.52 | 25,000 | 88,000 | 4,623,989 | Nov 17, 2021, 07:00 AM |
Grant Stuart M. | 10% Owner | Nov 15, 2021 | Buy | $3.64 | 75,000 | 272,750 | 4,598,989 | Nov 17, 2021, 07:00 AM |
Ianchulev Tsontcho | CHIEF EXECUTIVE OFFICER | Nov 03, 2021 | Buy | $4.04 | 30,000 | 121,206 | 579,895 | Nov 03, 2021, 07:54 PM |
Grant Stuart M. | 10% Owner | Oct 29, 2021 | Buy | $3.75 | 15,505 | 58,140 | 4,539,094 | Nov 02, 2021, 06:57 AM |
MATHER CHARLES E IV | Director | Nov 01, 2021 | Buy | $3.83 | 4,000 | 15,314 | 30,359 | Nov 01, 2021, 05:05 PM |
Rowe Michael M | CHIEF OPERATING OFFICER | Oct 27, 2021 | Buy | $4.14 | 1,200 | 4,968 | 5,500 | Oct 27, 2021, 04:02 PM |
Grant Stuart M. | 10% Owner | Oct 26, 2021 | Buy | $4.00 | 100,000 | 400,000 | 4,523,589 | Oct 27, 2021, 07:42 AM |
Grant Stuart M. | 10% Owner | Oct 25, 2021 | Buy | $4.00 | 33,806 | 135,224 | 4,423,589 | Oct 27, 2021, 07:42 AM |
Rowe Michael M | Chief Operating Officer | Sep 13, 2021 | Buy | $4.40 | 1,500 | 6,600 | 4,300 | Sep 13, 2021, 05:04 PM |
Grant Stuart M. | 10% Owner | Aug 19, 2021 | Buy | $3.98 | 50,000 | 198,984 | 4,389,783 | Aug 23, 2021, 06:00 AM |
Grant Stuart M. | 10% Owner | Aug 18, 2021 | Buy | $3.93 | 924 | 3,635 | 4,339,783 | Aug 19, 2021, 06:00 AM |
Grant Stuart M. | 10% Owner | Aug 17, 2021 | Buy | $4.00 | 23,419 | 93,676 | 4,338,859 | Aug 19, 2021, 06:00 AM |
Clasby Jennifer G | VP, Regulatory and Clinical | Jun 17, 2021 | Option Exercise | $5.42 | 13,675 | 74,119 | 66,537 | Jul 21, 2021, 12:21 PM |
Clasby Jennifer G | VP, Regulatory and Clinical | Jun 17, 2021 | Option Exercise | $1.95 | 24,510 | 47,795 | 80,212 | Jul 21, 2021, 12:21 PM |
Clasby Jennifer G | VP, Regulatory and Clinical | Jun 17, 2021 | Option Exercise | $5.42 | 14,262 | 77,300 | 65,950 | Jun 22, 2021, 11:33 AM |
Clasby Jennifer G | VP, Regulatory and Clinical | Jun 17, 2021 | Option Exercise | $1.95 | 24,510 | 47,795 | 80,212 | Jun 22, 2021, 11:33 AM |
Grant Stuart M. | 10% Owner | Apr 20, 2021 | Buy | $4.78 | 30,000 | 143,500 | 4,315,440 | Apr 20, 2021, 06:47 PM |
Grant Stuart M. | 10% Owner | Apr 19, 2021 | Buy | $4.89 | 30,692 | 150,163 | 4,285,440 | Apr 20, 2021, 06:47 PM |
Grant Stuart M. | 10% Owner | Mar 05, 2021 | Buy | $5.50 | 35,000 | 192,500 | 4,254,748 | Mar 08, 2021, 05:34 PM |
MARIO ERNEST | Director | Jan 15, 2021 | Option Exercise | $2.27 | 41,216 | 93,560 | 375,743 | Jan 19, 2021, 04:40 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jan 05, 2021 | Option Exercise | $2.27 | 41,216 | 93,560 | 549,895 | Jan 06, 2021, 04:59 PM |
GANDOLFO JOHN P | Chief Financial Officer | Nov 19, 2020 | Buy | $3.40 | 4,000 | 13,600 | 6,000 | Nov 23, 2020, 04:05 PM |
Clasby Jennifer G | VP, Clinical Operations | Sep 18, 2020 | Option Exercise | $1.95 | 26,737 | 52,137 | 55,702 | Oct 16, 2020, 05:04 PM |
Grant Stuart M. | 10% Owner | Oct 12, 2020 | Buy | $3.55 | 100,000 | 355,000 | 4,219,748 | Oct 13, 2020, 11:54 AM |
Grant Stuart M. | 10% Owner | Sep 24, 2020 | Buy | $2.99 | 75,000 | 224,500 | 4,119,748 | Sep 25, 2020, 01:42 PM |
Grant Stuart M. | 10% Owner | Aug 19, 2020 | Buy | $3.60 | 333,000 | 1,198,800 | 3,593,128 | Aug 24, 2020, 06:05 AM |
Grant Stuart M. | 10% Owner | Aug 20, 2020 | Buy | $2.06 | 451,620 | 929,434 | 4,044,748 | Aug 24, 2020, 06:05 AM |
Ianchulev Tsontcho | Chief Executive Officer | Mar 24, 2020 | Buy | $2.27 | 82,431 | 187,118 | 508,679 | Mar 26, 2020, 06:17 PM |
MARIO ERNEST | Director | Mar 24, 2020 | Buy | $2.27 | 82,431 | 187,118 | 327,239 | Mar 26, 2020, 06:12 PM |
Grant Stuart M. | 10% Owner | Mar 23, 2020 | Buy | $2.06 | 903,240 | 1,858,868 | 3,260,128 | Mar 25, 2020, 05:51 PM |
Rowe Michael M | Vice President, Commercial | Sep 30, 2019 | Buy | $3.84 | 100 | 384 | 1,400 | Feb 03, 2020, 05:13 PM |
Grant Stuart M. | 10% Owner | Sep 27, 2019 | Buy | $4.00 | 312 | 1,248 | 2,226,183 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 15, 2019 | Buy | $3.24 | 6,720 | 21,806 | 2,267,543 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Nov 12, 2019 | Buy | $2.70 | 29,945 | 80,762 | 2,346,888 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 14, 2019 | Buy | $3.25 | 6,700 | 21,775 | 2,260,823 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 31, 2019 | Buy | $2.71 | 6,072 | 16,449 | 2,316,943 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 02, 2019 | Buy | $3.33 | 5,000 | 16,650 | 2,254,123 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 30, 2019 | Buy | $2.85 | 25,000 | 71,350 | 2,310,871 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 01, 2019 | Buy | $3.44 | 5,000 | 17,200 | 2,249,123 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 17, 2019 | Buy | $3.01 | 3,328 | 10,017 | 2,285,871 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Sep 30, 2019 | Buy | $3.70 | 17,940 | 66,360 | 2,244,123 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Oct 16, 2019 | Buy | $3.14 | 15,000 | 47,055 | 2,282,543 | Nov 18, 2019, 06:01 AM |
Grant Stuart M. | 10% Owner | Nov 13, 2019 | Buy | $2.65 | 10,000 | 26,500 | 2,356,888 | Nov 18, 2019, 06:01 AM |
MARIO ERNEST | Director | Jul 11, 2019 | Buy | $2.78 | 35,971 | 99,999 | 272,741 | Jul 15, 2019, 05:46 PM |
LaBelle Curt H | Director | Jul 11, 2019 | Buy | $2.78 | 17,985 | 49,998 | 27,985 | Jul 15, 2019, 05:46 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jul 11, 2019 | Buy | $2.78 | 233,813 | 650,000 | 426,248 | Jul 15, 2019, 05:46 PM |
MARIO ERNEST | Director | Jan 29, 2018 | Buy | $10.00 | 90,000 | 900,000 | 236,770 | May 21, 2019, 05:24 PM |
Yoshida Shuhei | Director | May 14, 2019 | Option Exercise | $1.95 | 33,334 | 65,001 | 33,334 | May 16, 2019, 05:19 PM |
LaBelle Curt H | Director | Jan 02, 2019 | Option Exercise | $1.24 | 140,000 | 173,600 | 606,667 | Jan 03, 2019, 05:29 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jan 02, 2019 | Option Exercise | $1.24 | 140,000 | 173,600 | 606,667 | Jan 03, 2019, 05:28 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jan 02, 2019 | Option Exercise | $1.79 | 173,686 | 310,288 | 192,435 | Jan 03, 2019, 05:28 PM |
Rowe Michael M | Vice President of Marketing | Sep 25, 2018 | Buy | $4.27 | 600 | 2,562 | 1,000 | Sep 26, 2018, 05:21 PM |
Rowe Michael M | Vice President of Marketing | Sep 24, 2018 | Buy | $4.09 | 200 | 818 | 400 | Sep 26, 2018, 05:21 PM |
MATHER CHARLES E IV | Director | Sep 19, 2018 | Buy | $4.78 | 3,000 | 14,340 | 8,033 | Sep 20, 2018, 04:17 PM |
MATHER CHARLES E IV | Director | Sep 18, 2018 | Buy | $4.80 | 1,000 | 4,800 | 5,033 | Sep 20, 2018, 04:17 PM |
Clasby Jennifer G | VP, Clinical Operations | Sep 10, 2018 | Option Exercise | $1.95 | 28,965 | 56,482 | 28,965 | Sep 18, 2018, 04:45 PM |
GANDOLFO JOHN P | Chief Financial Officer | Jun 28, 2018 | Buy | $5.86 | 2,000 | 11,720 | 2,000 | Jul 02, 2018, 04:06 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jun 28, 2018 | Buy | $6.63 | 6,000 | 39,780 | 6,000 | Jul 02, 2018, 04:05 PM |
Yoshida Shuhei | Director | Jan 29, 2018 | Buy | $10.00 | 100,000 | 1,000,000 | 1,718,566 | Feb 09, 2018, 10:34 AM |
Senju Pharmaceutical Co., Ltd. | 10% Owner | Jan 29, 2018 | Buy | $10.00 | 100,000 | 1,000,000 | 1,718,566 | Feb 09, 2018, 10:25 AM |
LaBelle Curt H | Director | Jan 29, 2018 | Buy | $10.00 | 10,000 | 100,000 | 10,000 | Feb 08, 2018, 03:37 PM |
Ianchulev Tsontcho | Chief Executive Officer | Jan 29, 2018 | Buy | $10.00 | 10,000 | 100,000 | 18,749 | Feb 06, 2018, 10:04 AM |
ESHELMAN FREDRIC N | Director | Jan 29, 2018 | Buy | $10.00 | 335,000 | 3,350,000 | 1,273,428 | Feb 06, 2018, 10:00 AM |
Owner | Relationship | Date | Value($) |
Grant Stuart M. | 10% Owner | 06/21/2022 | 165,000 |
LEE KENNETH B JR | Director | 05/19/2022 | 22,000 |
MATHER CHARLES E IV | Director | 05/18/2022 | 14,232 |
Grant Stuart M. | 10% Owner | 05/11/2022 | 48,750 |
Grant Stuart M. | 10% Owner | 05/10/2022 | 99,000 |
Grant Stuart M. | 10% Owner | 05/05/2022 | 58,593 |
Grant Stuart M. | 10% Owner | 05/04/2022 | 54,407 |
Grant Stuart M. | 10% Owner | 04/21/2022 | 100,492 |
Grant Stuart M. | 10% Owner | 04/22/2022 | 51,000 |
MATHER CHARLES E IV | Director | 03/31/2022 | 12,460 |
Grant Stuart M. | 10% Owner | 02/22/2022 | 115,500 |
Grant Stuart M. | 10% Owner | 02/18/2022 | 28,500 |
Grant Stuart M. | 10% Owner | 02/07/2022 | 107,009 |
Grant Stuart M. | 10% Owner | 12/15/2021 | 345,000 |
Grant Stuart M. | 10% Owner | 11/16/2021 | 88,000 |
Grant Stuart M. | 10% Owner | 11/15/2021 | 272,750 |
Ianchulev Tsontcho | CHIEF EXECUTIVE OFFICER | 11/03/2021 | 121,206 |
Grant Stuart M. | 10% Owner | 10/29/2021 | 58,140 |
MATHER CHARLES E IV | Director | 11/01/2021 | 15,314 |
Rowe Michael M | CHIEF OPERATING OFFICER | 10/27/2021 | 4,968 |
Grant Stuart M. | 10% Owner | 10/26/2021 | 400,000 |
Grant Stuart M. | 10% Owner | 10/25/2021 | 135,224 |
Rowe Michael M | Chief Operating Officer | 09/13/2021 | 6,600 |
Grant Stuart M. | 10% Owner | 08/19/2021 | 198,984 |
Grant Stuart M. | 10% Owner | 08/18/2021 | 3,635 |
Grant Stuart M. | 10% Owner | 08/17/2021 | 93,676 |
Clasby Jennifer G | VP, Regulatory and Clinical | 06/17/2021 | 74,119 |
Clasby Jennifer G | VP, Regulatory and Clinical | 06/17/2021 | 47,795 |
Clasby Jennifer G | VP, Regulatory and Clinical | 06/17/2021 | 77,300 |
Clasby Jennifer G | VP, Regulatory and Clinical | 06/17/2021 | 47,795 |
Grant Stuart M. | 10% Owner | 04/20/2021 | 143,500 |
Grant Stuart M. | 10% Owner | 04/19/2021 | 150,163 |
Grant Stuart M. | 10% Owner | 03/05/2021 | 192,500 |
MARIO ERNEST | Director | 01/15/2021 | 93,560 |
Ianchulev Tsontcho | Chief Executive Officer | 01/05/2021 | 93,560 |
GANDOLFO JOHN P | Chief Financial Officer | 11/19/2020 | 13,600 |
Clasby Jennifer G | VP, Clinical Operations | 09/18/2020 | 52,137 |
Grant Stuart M. | 10% Owner | 10/12/2020 | 355,000 |
Grant Stuart M. | 10% Owner | 09/24/2020 | 224,500 |
Grant Stuart M. | 10% Owner | 08/19/2020 | 1,198,800 |
Grant Stuart M. | 10% Owner | 08/20/2020 | 929,434 |
Ianchulev Tsontcho | Chief Executive Officer | 03/24/2020 | 187,118 |
MARIO ERNEST | Director | 03/24/2020 | 187,118 |
Grant Stuart M. | 10% Owner | 03/23/2020 | 1,858,868 |
Rowe Michael M | Vice President, Commercial | 09/30/2019 | 384 |
Grant Stuart M. | 10% Owner | 09/27/2019 | 1,248 |
Grant Stuart M. | 10% Owner | 10/15/2019 | 21,806 |
Grant Stuart M. | 10% Owner | 11/12/2019 | 80,762 |
Grant Stuart M. | 10% Owner | 10/14/2019 | 21,775 |
Grant Stuart M. | 10% Owner | 10/31/2019 | 16,449 |
Grant Stuart M. | 10% Owner | 10/02/2019 | 16,650 |
Grant Stuart M. | 10% Owner | 10/30/2019 | 71,350 |
Grant Stuart M. | 10% Owner | 10/01/2019 | 17,200 |
Grant Stuart M. | 10% Owner | 10/17/2019 | 10,017 |
Grant Stuart M. | 10% Owner | 09/30/2019 | 66,360 |
Grant Stuart M. | 10% Owner | 10/16/2019 | 47,055 |
Grant Stuart M. | 10% Owner | 11/13/2019 | 26,500 |
MARIO ERNEST | Director | 07/11/2019 | 99,999 |
LaBelle Curt H | Director | 07/11/2019 | 49,998 |
Ianchulev Tsontcho | Chief Executive Officer | 07/11/2019 | 650,000 |
MARIO ERNEST | Director | 01/29/2018 | 900,000 |
Yoshida Shuhei | Director | 05/14/2019 | 65,001 |
LaBelle Curt H | Director | 01/02/2019 | 173,600 |
Ianchulev Tsontcho | Chief Executive Officer | 01/02/2019 | 173,600 |
Ianchulev Tsontcho | Chief Executive Officer | 01/02/2019 | 310,288 |
Rowe Michael M | Vice President of Marketing | 09/25/2018 | 2,562 |
Rowe Michael M | Vice President of Marketing | 09/24/2018 | 818 |
MATHER CHARLES E IV | Director | 09/19/2018 | 14,340 |
MATHER CHARLES E IV | Director | 09/18/2018 | 4,800 |
Clasby Jennifer G | VP, Clinical Operations | 09/10/2018 | 56,482 |
GANDOLFO JOHN P | Chief Financial Officer | 06/28/2018 | 11,720 |
Ianchulev Tsontcho | Chief Executive Officer | 06/28/2018 | 39,780 |
Yoshida Shuhei | Director | 01/29/2018 | 1,000,000 |
Senju Pharmaceutical Co., Ltd. | 10% Owner | 01/29/2018 | 1,000,000 |
LaBelle Curt H | Director | 01/29/2018 | 100,000 |
Ianchulev Tsontcho | Chief Executive Officer | 01/29/2018 | 100,000 |
ESHELMAN FREDRIC N | Director | 01/29/2018 | 3,350,000 |
Period of Report: 12/31/2021
10-K/10-Q Filings: View